Jazz Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. 

CEO
Bruce C. Cozadd
CEOBruce C. Cozadd
Employees
2,800
Employees2,800
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2005
Founded2005
Employees
2,800
Employees2,800

JAZZ Key Statistics

Market cap
6.57B
Market cap6.57B
Price-Earnings ratio
13.88
Price-Earnings ratio13.88
Dividend yield
Dividend yield
Average volume
1.75M
Average volume1.75M
High today
$108.69
High today$108.69
Low today
$103.88
Low today$103.88
Open price
$103.92
Open price$103.92
Volume
1.87M
Volume1.87M
52 Week high
$148.06
52 Week high$148.06
52 Week low
$95.49
52 Week low$95.49

JAZZ News

Simply Wall St 6d
Earnings Miss: Jazz Pharmaceuticals plc Missed EPS And Analysts Are Revising Their Forecasts

There's been a notable change in appetite for Jazz Pharmaceuticals plc ( ) shares in the week since its first-quarter report, with the stock down 16% to US$98.4...

Earnings Miss: Jazz Pharmaceuticals plc Missed EPS And Analysts Are Revising Their Forecasts

Analyst ratings

90%

of 20 ratings
Buy
90%
Hold
10%
Sell
0%

People also own

Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.